# Stem Cell Therapy in Patients With Severe Heart Failure & Undergoing Left Ventricular Assist Device Placement

> **NCT00869024** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 25 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **BIOLOGICAL:** Intramyocardial Delivery of Bone Marrow Derived Mononuclear Cells

## Key facts

- **NCT ID:** NCT00869024
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11-10
- **Primary completion:** 2016-03-29
- **Final completion:** 2016-03-29
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2020-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00869024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00869024, "Stem Cell Therapy in Patients With Severe Heart Failure & Undergoing Left Ventricular Assist Device Placement". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00869024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*